The article by Nguyen et al., that appeared in the August 2021 issue of Transplantation Direct, contained the following author errors:
The first sentence of the Materials and Methods section, “We studied 123 983 first-time adult KT-only recipients between January 1, 2000 and December 31, 2016, as reported by the Organ Procurement and Transplantation Network and linked to Medicare claims data by the US Renal Data System (USRDS),” should have included the following reference:
U.S. Renal Data System. 2021 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2021.
The Acknowledgments should have appeared as follows:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.
In Table 1, the separate categories “Others” and “Not reported” under Recipient Race and Donor Race should have appeared as “Others or not reported.”
TABLE 1.
Characteristics of kidney transplant (KT) recipients with and without pretransplant pulmonary hypertension (PtPH)
| Without PtPH(n=88178) | With PtPH(n=2641) | P-value | |
|---|---|---|---|
| RECIPIENT | |||
| Age at transplant, mean (SD) | 52.5 (13.5) | 55.7 (12.1) | <0.001 |
| Female | 33861 (38.4%) | 1004 (38.0%) | 0.69 |
| Race | <0.001 | ||
| White | 49015 (55.6%) | 1325 (50.2%) | |
| Black | 31756 (36.0%) | 1110 (42.0%) | |
| Asian | 4351 (4.9%) | 122 (4.6%) | |
| Others or not reported | 3056 (3.5%) | 84 (3.2%) | |
| Hispanic ethnicity | 16497 (18.8%) | 460 (17.5%) | 0.081 |
| BMI, median (IQR) | 27.7 (24.0, 31.8) (n=81954) | 27.1 (23.7, 31.3) (n=2514) | <0.001 |
| Pre-transplant dialysis | 88177 (100.0%) | 2641 (100.0%) | 1.0 |
| Dialysis vintage, median (IQR) | 4.3 (2.8, 6.1) (n=88177) | 5.9 (4.0, 8.1) (n=2641) | <0.001 |
| Comorbidities | |||
| HTN | 76415 (86.8%) | 2352 (89.2%) | <0.001 |
| DM | 32950 (37.4%) | 1252 (47.5%) | <0.001 |
| COPD | 1458 (1.8%) | 66 (2.6%) | 0.001 |
| CAD | 7289 (8.4%) | 308 (11.7%) | <0.001 |
| CHF | 10576 (12.8%) | 493 (19.7%) | <0.001 |
| OSA | 7303 (8.3%) | 574 (21.7.%) | <0.001 |
| Primary ESRD Diagnosis | <0.001 | ||
| Glomerular diseases | 18568 (21.1%) | 469 (17.8%) | |
| DM | 25639 (29.1%) | 969 (36.7%) | |
| HTN | 25820 (29.3%) | 819 (31.0%) | |
| PCKD | 5773 (6.5%) | 120 (4.5%) | |
| Neoplasm/tumor | 362 (0.4%) | 13 (0.5%) | |
| Other | 3736 (4.2%) | 79 (3.0%) | |
| Not reported | 8280 (9.4%) | 172 (6.5%) | |
| DONOR | |||
| Age, mean (SD) | 39.8 (15.3) (n=88177) | 41.2 (14.6) (n=2641) | <0.001 |
| Female | 38502 (43.7%) | 1164 (44.1%) | 0.68 |
| Race | 0.23 | ||
| White | 71483 (81.1%) | 2104 (79.7%) | |
| Black | 13494 (15.3%) | 442 (16.7%) | |
| Asian | 2232 (2.5%) | 69 (2.6%) | |
| Others or not reported | 969 (1.1%) | 26 (1.0%) | |
| Ethnicity | 13741 (15.6%) | 367 (13.9%) | 0.018 |
| BMI, median (IQR) | 26.5 (23.2, 30.4) (n=84534) | 26.8 (23.4, 30.9) (n=2546) | 0.030 |
| Comorbidities HTN | 20640 (24.7%) | 704 (27.5%) | 0.001 |
| DM | 5054 (6.0%) | 164 (6.4%) | 0.46 |
| Donor type Living donor | 15194 (17.2%) | 405 (15.3%) | 0.011 |
| DCD | 9357 (12.8%) | 357 (16.0%) | <0.001 |
| TRANSPLANT | |||
| HLA mismatches, median (IQR) | 5.0 (4.0, 6.0) (n=87066) | 5.0 (5.0, 6.0) (n=2611) | <0.001 |
| CIT, median (IQR) | 15.0 (9.0, 22.0) (n=80743) | 15.0 (9.0, 22.0) (n=2489) | 0.93 |
| CIT over 24 hours | 15691 (19.4%) | 464 (18.6%) | 0.43 |
BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disorder; CAD, coronary artery disease; CHF, congestive heart failure; ESRD, end stage renal disease; PCKD, polycystic kidney disease; DCD, donation after cardiac death; HLA, human leukocyte antigen; CIT, cold ischemia time
In Table 3, the separate categories “Probable Hispanic origin” and “Missing” under Ethnicity should have appeared as “Probable Hispanic origin or missing.” The separate categories “Others” and “Missing” under Primary ESRD Diagnosis, should have appeared as “Others or missing.”
TABLE 3.
Characteristics of candidates with pulmonary hypertension (PH) who received a kidney transplant (KT) or remained on the waitlist.
| KT(n=2331) | Waitlist(n=2331) | p-value | |
|---|---|---|---|
| Age at listing, mean (SD) | 52.8 (12.3) | 52.6 (11.5) | 0.67 |
| Female gender | 900 (38.6%) | 1051 (45.1%) | <0.001 |
| Race | 0.002 | ||
| White | 1181 (50.7%) | 1054 (45.2%) | |
| Black | 985 (42.3%) | 1099 (47.1%) | |
| Asian | 102 (4.4%) | 102 (4.4%) | |
| Others | 63 (2.7%) | 76 (3.3%) | |
| Ethnicity | 0.82 | ||
| Non Hispanic | 1908 (81.9%) | 1901 (81.6%) | |
| Probable Hispanic origin or missing | 423 (18.1%) | 430 (18.4%) | |
| BMI, mean (SD) | 28.2 (5.56) (n=2325) | 28.6 (5.90) (n=2286) | <0.001 |
| ABO blood group | <0.001 | ||
| O | 1101 (47.2%) | 1258 (54.0%) | |
| A | 795 (34.1%) | 565 (24.2%) | |
| B | 327 (14.0%) | 436 (18.7%) | |
| AB | 108 (4.6%) | 72 (3.1%) | |
| Primary ESRD Diagnosis | 0.032 | ||
| DM | 925 (39.7%) | 983 (42.2%) | |
| HTN | 675 (29.0%) | 647 (27.8%) | |
| GN | 478 (20.5%) | 419 (18.0%) | |
| PCKD | 84 (3.6%) | 75 (3.2%) | |
| Others or missing | 169 (7.3%) | 207 (8.9%) | |
| Dialysis vintage, median (IQR) | 1.68 (0.72, 3.73) | 1.50 (0.71, 3.05) | 0.002 |
| Maximum PRA, median (IQR) | 0 (0, 26.7) | 0.3 (0, 45) | <0.001 |
BMI, body mass index; ESRD, end stage renal disease; DM, diabetes mellitus; HTN, hypertension; GN, glomerulonephritis; PCKD, polycystic kidney disease
The corrected tables appear below.
REFERENCE
- 1.Nguyen MC, Chiang TP, Massie AB, et al. Kidney transplantation confers survival benefit for candidates with pulmonary hypertension. Transplant Direct. 2021;7:e738; doi: 10.1097/TXD.0000000000001191. [DOI] [PMC free article] [PubMed] [Google Scholar]
